Copeland Capital Management, LLC Abbott Laboratories Transaction History

Copeland Capital Management, LLC

$5.61 Billion
Q3 2024

A detailed history of Copeland Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Copeland Capital Management, LLC holds 1,248 shares of ABT stock, worth $146,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,248

Holding current value

$146,964

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$100.07 - $118.13 $124,887 - $147,426	1,248 New	1,248 $142,000
Q3 2021 Jan 18, 2022	BUY	$116.66 - $129.06 $145,591 - $161,066	1,248 New	1,248 $147,000
Q3 2021 Oct 20, 2021	SELL	$116.66 - $129.06 $145,591 - $161,066	-1,248 Closed	0 $0
Q2 2021 Jan 18, 2022	BUY	$105.79 - $124.53 $132,025 - $155,413	1,248 New	1,248 $145,000
Q2 2021 Jul 19, 2021	SELL	$105.79 - $124.53 $132,025 - $155,413	-1,248 Closed	0 $0
Q1 2021 Jan 18, 2022	BUY	$108.84 - $128.23 $135,832 - $160,031	1,248 New	1,248 $150,000
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $135,832 - $160,031	-1,248 Closed	0 $0
Q4 2020 Jan 18, 2022	BUY	$105.0 - $114.42 $131,040 - $142,796	1,248 New	1,248 $137,000
Q4 2020 Jan 27, 2021	SELL	$105.0 - $114.42 $131,040 - $142,796	-1,248 Closed	0 $0
Q3 2020 Jan 18, 2022	BUY	$91.64 - $111.29 $114,366 - $138,889	1,248 New	1,248 $136,000
Q3 2020 Oct 22, 2020	SELL	$91.64 - $111.29 $114,366 - $138,889	-1,248 Closed	0 $0
Q2 2020 Jan 18, 2022	BUY	$76.57 - $98.0 $95,559 - $122,304	1,248 New	1,248 $114,000
Q2 2020 Jul 30, 2020	SELL	$76.57 - $98.0 $95,559 - $122,304	-1,248 Closed	0 $0
Q1 2020 Jan 18, 2022	BUY	$62.82 - $91.86 $78,399 - $114,641	1,248 New	1,248 $98,000
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $78,399 - $114,641	-1,248 Closed	0 $0
Q4 2019 Jan 18, 2022	BUY	$78.51 - $87.4 $97,980 - $109,075	1,248 New	1,248 $108,000
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $97,980 - $109,075	-1,248 Closed	0 $0
Q3 2019 Jan 18, 2022	BUY	$81.84 - $88.74 $102,136 - $110,747	1,248 New	1,248 $104,000
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $102,136 - $110,747	-1,248 Closed	0 $0
Q2 2019 Jan 18, 2022	BUY	$72.88 - $85.0 $90,954 - $106,080	1,248 New	1,248 $105,000
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $90,954 - $106,080	-1,248 Closed	0 $0
Q1 2019 Jan 18, 2022	BUY	$66.22 - $80.06 $82,642 - $99,914	1,248 New	1,248 $100,000
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $82,642 - $99,914	-1,248 Closed	0 $0
Q4 2018 Jan 18, 2022	BUY	$65.56 - $74.27 $81,818 - $92,688	1,248 New	1,248 $90,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copeland Capital Management, LLC with notifications on news.

Account

Copeland Capital Management, LLC Abbott Laboratories Transaction History